$16.38
0.583.67%
At close: Aug 21, 5:00 PM EST
$15.80
-0.58-3.54%
After Hours: Aug 20, 4:00 PM EST
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Calculators
Compare Best Stocks
BlossomHill Therapeutics Ownership & Insider Activity
BlossomHill Therapeutics (BLSM) institutional and insider ownership, recent insider transactions and ownership breakdown.
Shares Outstanding
29.081M
Net Insider Activity by Month
Purchases (90d)
6
$25.2M total
Sales (90d)
0
Net Activity
Net Buying
Net Value (90d)
$25.2M
BlossomHill Therapeutics Insider Transactions (Last 6 Months)
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Carl L Gordon | DIRECTOR | BUY | 2.714M | $16.00 | $10.0M |
| Aug 10, 2026 | ORBIMED ADVISORS LLC, OrbiMed Capital GP VIII LLC | DIRECTOR | BUY | 2.714M | $16.00 | $10.0M |
| Aug 10, 2026 | John Schmid | — | BUY | 6.000K | $16.00 | $96K |
| Aug 10, 2026 | Bihua Chen, Cormorant Asset Management LP, Cormorant Global Healthcare Master Fund LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund V LP, Cormorant Private Healthcare Fund VI LP | 10% OWNER | BUY | 3.614M | $16.00 | $5.0M |
| Aug 10, 2026 | Jason Keyes | CHIEF FINANCIAL OFFICER | BUY | 700.000 | $16.00 | $11K |
| Aug 7, 2026 | Vincent Liptak | GENERAL COUNSEL | BUY | 27.387K | $15.89 | $75K |
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved